Channels - Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response :: FRELIP Discovery

Similar Items: Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response

Quick Look
Immune subtyping of colorectal adenoma identifies a subtype with activated adaptive immunity ahead of progressing to cancer
Quick Look
Pan-cancer integrative profiling of immune-related lncRNAs unveils tumor microenvironment subtypes and prognostic biomarkers
Quick Look
Multi-omics pan-cancer analysis reveals heterogeneous BCAA metabolism and its impact on the tumor immune microenvironment and prognosis
Quick Look
Comprehensive pan-cancer analysis of MEX3C in human tumors
Quick Look
A pan-cancer analysis of MEX3D in human tumors
Quick Look
Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics
Quick Look
Platelet–Prostate cancer crosstalk driving disparities and therapeutic vulnerabilities
Quick Look
Metformin in endometrial cancer from metabolic regulation to precision therapeutics
Quick Look
The adenosine A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implications
Quick Look
The potential utility of in-silico approach in identifying phytochemicals against various targets for the management of lung cancer
Quick Look
Dual roles of mesenchymal, neural, and induced pluripotent stem cells in cancer: implications for tumorigenesis and therapeutic applications
Quick Look
Identifying the relationship between exosome genes and breast cancer risk using bioinformatics and machine learning methods
Quick Look
Artificial intelligence and multi-omics revealed the authentic regulation of ADP-ribosylation in modulation Treg/Th17 ecosystem and multi-target therapeutic strategy enrichment for HBV+ Hepatocellular Carcinoma patients
Quick Look
Transcription factors remodel tumor immune microenvironment by impacting multiple immune cells
Quick Look
Network toxicology and molecular docking identify BRCA1 as a functional target of the dietary carcinogen PhIP in colorectal cancer
Quick Look
Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer
Quick Look
A novel model for assessing lymph node metastasis and the immune microenvironment in breast cancer by integrating digital pathology images and transcriptomics
Quick Look
Derivation and external validation of a prognostic nomogram for human epidermal growth factor receptor 2 negative early young breast cancer in women
Quick Look
Machine learning-assisted screening of natural product database for the identification of novel chalcone-based derivative as a potent DHODH inhibitor in cancer therapy
Quick Look
Identification of hub mRNAs and long non-coding RNAs involved in temozolomide-resistant glioblastoma (brain cancer) cell lines
Quick Look
miR-34a-5p-mediated inhibition on the KRT5/DSP axis blunts cancer stem cell properties and cisplatin resistance in non-small cell lung cancer
Quick Look
Bioinformatic analysis reveals the potential association of ESRP1 with the splicing of cytoskeleton-associated genes in doxorubicin-resistant MCF7 breast cancer cells
Quick Look
Proteomic stratification reveals immune metabolic heterogeneity in lung adenocarcinoma
Quick Look
Desmoglein 2 is associated with dihydroartemisinin resistance in HeLa cervical cancer cells: a potential link to the PI3K/AKT signaling pathway